The number of people with susceptibility test result for rifampicin in Nicaragua

Nicaragua: The number of people with susceptibility test result for rifampicin was 627 in 2021. ▲ Rising

Latest (2021)
627
Change on year
down 50.3%
World rank
74th
of 155 countries
All-time high
1,262
in 2020
All-time low
396
in 2017
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Nicaragua, 2017–2021

4006008001.0k1.2k2017201920212017: 3962018: 1.0k2019: 6092020: 1.3k2021: 627

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Nicaragua is 627, measured in 2021.

That represents a change of down 50.3% on the previous year and up 58.3% over five years.

Nicaragua ranks 74th of 155 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in Nicaragua, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Nicaragua, 2017 to 2021.
Year Value Change
2017 396
2018 1,021 +157.8%
2019 609 -40.4%
2020 1,262 +107.2%
2021 627 -50.3%

Nicaragua compared with similar countries

  • Nicaragua's 627 is below the median for lower middle income countries, which is 2,804, 22% of the median. (32 countries reporting)
  • Nicaragua's 627 is above the median for Latin America & Caribbean, which is 406.5, 1.5× the median. (26 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 675.33 396 1,021 3
2020s 944.5 627 1,262 2

Countries ranked near Nicaragua

  1. 71 Syrian Arab Republic 705 compare
  2. 72 Honduras 690 compare
  3. 73 Central African Republic 660 compare
  4. 75 Iraq 618 compare
  5. 76 Australia 597 compare
  6. 77 Saudi Arabia 591 compare

See the full ranking of 157 places →

More health data for Nicaragua

All data for Nicaragua →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Nicaragua?
The number of people with susceptibility test result for rifampicin in Nicaragua was 627 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Nicaragua?
The highest recorded value was 1,262 in 2020.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Nicaragua?
The lowest recorded value was 396 in 2017.
How does Nicaragua rank for the number of people with susceptibility test result for rifampicin?
Nicaragua ranks 74th out of 155 countries with data for 2021.
Where does this Nicaragua data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Nicaragua. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/nicaragua/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/nicaragua/">The number of people with susceptibility test result for rifampicin in Nicaragua</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed